is tirzepatide fda approved for weight loss Semaglutide vs. Tirzepatide: Which Treatment Right You? Choosing between Tirzepatide For Weight Loss In

The molecule, initially marketed for pediatric use, was withdrawn as a therapeutic entity but gained renewed attention for its potential in GHRT for aging adults

GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide are supported by STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)

Helps in generating energy, it reduces fatigue, it improves mental clarity, and it improves overall well-being

You might begin to notice some changes, like feeling less hungry, within the first week

Patients usually do best when expectations are realistic